ArticleDiscover oncology2024

Preclinical efficacy of CBR-5884 against epithelial ovarian cancer cells by targeting the serine synthesis pathway.

Kunxiang Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.